1. Choby JE, Howard-Anderson J, Weiss DS. Hypervirulent Klebsiella pneumoniae: clinical and molecular perspectives. J Intern Med. 2020; 287:283–300.
2. Harada S, Ishii Y, Saga T, Aoki K, Tateda K. Molecular epidemiology of Klebsiella pneumoniae K1 and K2 isolates in Japan. Diagn Microbiol Infect Dis. 2018; 91:354–9.
Article
3. Hsu PJ, Lee CH, Lee FY, Liu JW. Clinical and microbiological characteristics of mycotic aneurysms in a medical center in southern Taiwan. J Microbiol Immunol Infect. 2008; 41:318–24.
4. Lam MM, Wyres KL, Duchêne S, Wick RR, Judd LM, Gan YH, et al. Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global dissemination. Nat Commun. 2018; 9:2703.
Article
5. Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev. 2019; 15. 3:e00001–19.
Article
6. Siu LK, Yeh KM, Lin JC, Fung CP, Chang FY. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis. 2012; 12:881–7.
Article
7. Martin RM, Bachman MA. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol. 2018; 8:4.
Article
8. Cubero M, Marti S, Domínguez MÁ, González-Díaz A, Berbel D, Ardanuy C. Hypervirulent Klebsiella pneumoniae serotype K1 clinical isolates form robust biofilms at the air-liquid interface. PLoS One. 2019; 14:e0222628.
Article
9. Namikawa H, Yamada K, Fujimoto H, Oinuma KI, Tochino Y, Takemoto Y, et al. Two unusual cases of successful treatment of hypermucoviscous Klebsiella pneumoniae invasive syndrome. BMC Infect Dis. 2016; 16:680.
Article
10. Chen YJ, Chen SY, Wang JT, Hsueh PR. Mycotic aneurysm caused by gas-forming serotype K5 Klebsiella pneumoniae. Int J Infect Dis. 2009; 13:e47–8.
Article